Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients

Claudio Coco, Gian Franco Zannoni, Alessandro Sgambato, Emanuele Caredda, Stefano Sioletic, Alma Boninsegna Lucarelli, Giannicola Genovese, Egidio Stigliano, Achille Renato Maria Cittadini, Mario Migaldi, Luca Reggiani Bonetti

Risultato della ricerca: Contributo in rivistaArticolo in rivista

44 Citazioni (Scopus)

Abstract

Expression levels of CD133, a cancer stem cell marker, and of the α-subunit of the dystroglycan (α-DG) complex, have been previously reported to be altered in colorectal cancers.
Lingua originaleEnglish
pagine (da-a)71-71
Numero di pagine1
RivistaJOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume31
DOI
Stato di pubblicazionePubblicato - 2012

Keywords

  • CD133
  • colon cancer

Fingerprint

Entra nei temi di ricerca di 'Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients'. Insieme formano una fingerprint unica.

Cita questo